SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (6913)7/23/1999 11:50:00 AM
From: biowa  Respond to of 9719
 
V1,

Congrats again. Great, now I'm going to have to get up in the middle of the night to monitor European wires to stay ahead of you. <g>

biowa

From BusinessWire:

Coulter Pharmaceutical, Inc. (Nasdaq:CLTR) and SmithKline-Beecham (NYSE:SBH) today announced that Bexxar(TM) (tositumomab, iodine I 131 tositumomab) has been assigned priority review status by the U.S. Food and Drug Administration...